Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 5, 2005
[Sentinel node navigation surgery in uterine cancer]Hiroki Nakayama, Motohiro Shimizu, Takashi Yamada, et al.
American Journal of Hypertension|December 31, 2014
Correlation of Central Blood Pressure to Hypertensive Target Organ Damages During Antihypertensive Treatment: The J-TOP StudyMotohiro Shimizu, Satoshi Hoshide, Joji Ishikawa, et al.
American Journal of Hypertension|March 28, 2009
Association of an abnormal blood glucose level and morning blood pressure surge in elderly subjects with hypertensionMotohiro Shimizu, Joji Ishikawa, Kazuo Eguchi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 6, 2012
Is home blood pressure variability itself an interventional target beyond lowering mean home blood pressure during anti-hypertensive treatment?Satoshi Hoshide, Yuichiro Yano, Motohiro Shimizu, et al.
World Journal of Gastroenterology|April 28, 2015
Direct-acting antiviral-based triple therapy on alpha-fetoprotein level in chronic hepatitis C patientsKoji Takayama, Norihiro Furusyo, Eiichi Ogawa, et al.
Journal of Hypertension|June 12, 2009
Association between the morning-evening difference in home blood pressure and cardiac damage in untreated hypertensive patientsYoshio Matsui, Kazuo Eguchi, Seiichi Shibasaki, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 19, 2008
Cardiovascular risks of dipping status and chronic kidney disease in elderly Japanese hypertensive patientsJoji Ishikawa, Motohiro Shimizu, Satoshi Hoshide, et al.
Journal of Hypertension|December 12, 2013
Assessment of the reductions in night-time blood pressure and dipping induced by antihypertensive medication using a home blood pressure monitorJoji Ishikawa, Motohiro Shimizu, Eijiro Sugiyama Edison, et al.
Antiviral Therapy|September 16, 2016
Comparison of the Abbott RealTime HCV and Roche COBAS Ampliprep/COBAS TaqMan HCV assays for the monitoring of sofosbuvir-based therapyEiichi Ogawa, Norihiro Furusyo, Masayuki Murata, et al.
Pageof 5